Mycobacterium chimaera chorioretinitis as a biomarker of systemic disease activity following nosocomial acquisition during cardiopulmonary bypass.
Michael ColuccielloPublished in: Postgraduate medicine (2019)
Objectives: To understand the role of ophthalmoscopic examination (dilated retina examination and widefield fundus photography) in the diagnosis and management of nosocomial acquisition of Mycobacterium chimaera following open heart surgery with cardiopulmonary bypass utilizing a heater-cooler unit, an entity that is associated with >50% mortality during the worldwide outbreak that has occurred since 2013.Methods: Case report with review of previous cases.Results: Signature Mycobacterium chimaera chorioretinal lesions can be used as a diagnostic sign and a biomarker for assessment of treatment efficacy.Conclusions: Ophthalmologic examination can play a key role in diagnosis and management of systemic Mycobacterium chimaera following cardiopulmonary bypass; such examinations may yield earlier diagnosis, diminishing mortality rates.
Keyphrases
- mycobacterium tuberculosis
- disease activity
- minimally invasive
- rheumatoid arthritis
- systemic lupus erythematosus
- case report
- cardiovascular events
- rheumatoid arthritis patients
- acinetobacter baumannii
- diabetic retinopathy
- risk factors
- methicillin resistant staphylococcus aureus
- heart failure
- klebsiella pneumoniae
- atrial fibrillation
- multidrug resistant
- drug induced
- acute coronary syndrome
- combination therapy
- percutaneous coronary intervention